Based on fundamentals, market trends, company events and news, and other factors, equity analysts assign price targets and recommendations to buy or sell a stock. The following graph shows how a survey of multiple analysts recommend …
Endo International plc ENDP recently announced preliminary results for first-quarter 2017. The company projects first ... to Consider Endo currently carries a Zacks Rank #5 (Strong Sell) stock. Some better-ranked stocks in the health care …
Yahoo!7mon
Ireland-domiciled specialty pharmaceutical company, Endo International plc’s ENDP shares touched a 52-week low of $ ... Valeant has made it to the headlines for all the wrong reasons and seen its stock spiraling down. Earlier this week, the …
More than 183,000 people died from overdoses related to prescription opioid painkillers like oxycodone, hydrocodone, …
Endo International plc is a generics and specialty branded pharmaceutical company. The Company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals and International Pharmaceuticals. It …
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content.
Endo International Plc : FDA staff: postmarketing data suggests opana er reformulation likely reduced nasal abuse rates, but data limitations makes it hard to determine magnitude of effect . FDA staff: postmarketing data indicate an increase …
Buffalo Wild Wings downgraded at Miller Tabak from Buy to Hold. Valuation call, based on a $148 price target. Cardinal Health upgraded at Sterne Agee to Buy from Neutral. $73 price target. Should deliver superior EPS growth relative to …